AtaiBeckley (ATAI) Operating Leases (2022 - 2026)

AtaiBeckley (ATAI) recorded quarterly Operating Leases of $1.7 million in Q1 2026, down 6.16% quarter-over-quarter from $1.8 million in Q4 2025.

AtaiBeckley (ATAI) Operating Leases (2022 - 2026) Analysis & Trends

AtaiBeckley's Operating Leases history runs 3 years deep, the most recent figure standing at $1.7 million for Q1 2026.

  • In Q1 2026, Operating Leases changed N/A year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (changed N/A YoY), while the FY2025 annual figure was $1.8 million, up 146.04% from the prior year.
  • Operating Leases was $1.7 million for Q1 2026 at AtaiBeckley, down from $1.8 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $2.6 million in Q2 2025 to a low of $44000.0 in Q4 2022.
  • The 4-year median for Operating Leases is $1.0 million (2023), against an average of $1.3 million.
  • Biggest YoY gain for Operating Leases was 146.04% in 2025; the steepest drop was 146.04% in 2025.
  • A 3-year view of Operating Leases shows it stood at $732000.0 in 2024, then soared by 146.04% to $1.8 million in 2025, then decreased by 6.16% to $1.7 million in 2026.
  • The last three Operating Leases figures came in at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $732000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 AtaiBeckley 1.45 Bn 1.45 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.69 Mn
Dec 31, 2025 1.80 Mn
Sep 30, 2025 2.43 Mn
Jun 30, 2025 2.62 Mn
Mar 31, 2025 2.59 Mn
Dec 31, 2024 732,000.00
Dec 31, 2024 732,000.00
Sep 30, 2024 808,000.00
Jun 30, 2024 838,000.00
Mar 31, 2024 907,000.00
Dec 31, 2023 990,000.00
Sep 30, 2023 1.01 Mn
Jun 30, 2023 1.10 Mn
Mar 31, 2023 1.19 Mn
Dec 31, 2022 44,000.00